Publication Results (215)

• «
• 1
• 2
• 3
• 4
• 5
• 6
• »

• Rates and risk factors for prolonged opioid use after major surgery: population based cohort study

  Clarke H, Soneji N, Ko DT, Yun L, Wijeysundera DN. BMJ. 2014; 348:g1251. Epub 2014 Feb 11.

• A comparison of Chinese and non-Chinese Canadian patients hospitalized with heart failure

  Yeung DF, Van Dyke NK, Maclagan LC, Moe GW, Shah BR, Chiu M, Lee DS, Ko DT, Lau C, Tu JV. BMC Cardiovasc Disord. 2013; 13:114.

• Duration of preoperative β-blockade and outcomes after major elective noncardiac surgery

  Wijeysundera DN, Beattie WS, Wijeysundera HC, Yun L, Austin PC, Ko DT. Can J Cardiol. 2013; 30(2):217-23. Epub 2013 Oct 24.

• Predictors of normal coronary arteries at coronary angiography

  Levitt K, Guo H, Wijeysundera HC, Ko DT, Natarajan MK, Feindel CM, Kingsbury K, Cohen EA, Tu JV. Am Heart J. 2013; 166(4):694-700. Epub 2013 Sep 18.

• Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario

  Ko DT, Tu JV, Austin PC, Wijeysundera HC, Samadashvili Z, Guo HC, Cantor WJ, Hannan EL. JAMA. 2013; 310 (2):163-9. Epub 2013 Apr 6.

• Use of niacin in the United States and Canada

  Jackevicius CA, Tu JV, Ko DT, de Leon N, Krumholz HM. JAMA Intern Med. 2013; 173(14):1379-81. Epub 2013 Jun 10.

• Quality of diabetes and hyperlipidemia screening before a first myocardial infarction

  Lugomirski P, Guo H, Boom NK, Donovan LR, Ko DT, Tu JV. Can J Cardiol. 2013; 29(11):1382-7. Epub 2013 Jun 6.

• Socioeconomic status, functional recovery, and long-term mortality among patients surviving acute myocardial infarction

  Alter DA, Franklin B, Ko DT, Austin PC, Lee DS, Oh Pl, Stukel TA, Tu JV. PLoS One. 2013; 8(6):e65130. Epub 2013 Jun 3.

• Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins

  Ko DT, Wijeysundera H, Jackevicius CA, Wang J, Tu JV. Circ Cardiovasc Qual Outcomes. 2013; 6(3):315-22. Epub 2013 May 14.

• Association between physician follow-up and outcomes of care after chest pain assessment in high-risk patients

  Czarnecki A, Chong A, Lee DS, Schull MJ, Tu JV, Lau C, Farkouh ME, Ko DT. Circulation. 2013; 127(13):1386-94.

• A population-based study to evaluate the effectiveness of multi-disciplinary heart failure clinics and identify important service components

  Wijeysundera HC, Trubiani G, Wang X, Mitsakakis N, Austin PC, Ko DT, Lee DS, Tu JV, Krahn M. Circ Heart Fail. 2013; 6(1):68-75. Epub 2012 Dec 10.

• Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease

  Ko DT, Guo H, Wijeysundera HC, Natarajan MK, Nagpal AD, Feindel CM, Kingsbury K, Cohen EA, Tu JV; Cardiac Care Network (CCN) of Ontario Variations in Revascularization Practice in Ontario (VRPO) Working Group.. J Am Coll Cardiol. 2012; 60(19):1876-84. Epub 2012 Oct 10.

• Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study

  Wijeysundera DN, Wijeysundera HC, Yun L, Wąsowicz M, Beattie SW, Velianou JL, Ko DT. Circulation. 2012; 126(11):1355-62. Epub 2012 Aug 14.

• Techniques for estimating health care costs with censored data: an overview for the health services researcher

  Wijeysundera HC, Wang X, Tomlinson G, Ko DT, Krahn MD. Clinicoecon Outcomes Res. 2012; 4:144-55. Epub 2012 Jun 1.

• The average lifespan of patients discharged from hospital with heart failure

  Alter DA, Ko DT, Tu JV, Stukel TA, Lee DS, Laupacis A, Chong A, Austin PC. J Gen Intern Med. 2012; 27(9):1171-9. Epub 2012 May 2.

• Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals

  Stukel TA, Fisher ES, Alter DA, Guttmann A, Ko DT, Fung K, Wodchis WP, Baxter NN, Earle CC, Lee DS. JAMA. 2012; 307(10):1037-45.

• Determinants of variations in coronary revascularization practices

  Tu JV, Ko DT, Guo H, Richards JA, Walton N, Natarajan MK, Wijeysundera HC, So D, Latter DA, Feindel CM, Kingsbury K, Cohen EA; Cardiac Care Network of Ontario’s Variations in Revascularization Practice in Ontario Working Group. CMAJ. 2012; 184(2):179-86. Epub 2011 Dec 12.

• Long-term safety and effectiveness of drug-eluting stents for the treatment of saphenous vein grafts disease: a population-based study

  Ko DT, Guo H, Wijeysundera HC, Zia MI, Dzavik V, Chu MW, Fremes SE, Cohen EA, Tu JV. JACC Cardiovasc Interv. 2011; 4(9):965-73.

• Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions

  Ko DT, Wijeysundera HC, Yun L, Austin PC, Cantor WJ, Tu JV. Circ Cardiovasc Qual Outcomes. 2011; 4(4):459-66. Epub 2011 Jun 28.

• Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial infarction: a population-based study

  Ko DT, Atzema CL, Donovan LR, Graham MM, Huynh T, So DY, Wang J, Wijeysundera HC. Tu JV. Am Heart J. 2011; 161(4):764-70.

• Use of fibrates in the United States and Canada

  Jackevicius CA, Tu JV, Ross JS, Ko DT, Carreon D, Krumholz HM. JAMA. 2011; 305(12):1217-24. Epub 2011 Mar 23.

• Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief

  Wijeysundera HC, Nallamothu BK, Krumholz HM, Tu JV, Ko DT. Ann Intern Med. 2010; 152(6):370-9.

• Secular trends in acute coronary syndrome hospitalization from 1994 to 2005

  Ko DT, Newman AM, Alter DA, Austin PC, Chiu M, Cox JL, Goodman SG, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2010; 26(3):129-34.

• Association between hospital cardiac management and outcomes for acute myocardial infarction patients

  Stukel TA, Alter DA, Schull MJ, Ko DT, Li P. Med Care. 2010; 48(2):157-65.

• Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial

  Tu JV, Donovan LR, Lee DS, Wang JT, Austin PC, Alter DA, Ko DT. JAMA. 2009; 302(21):2330-7. Epub 2009 Nov 18.

• Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents

  Ko DT, Chiu M, Guo H, Austin PC, Marquis JF, Tu JV. Ann Heart J. 2009; 158(4):592-8.e1. Epub 2009 Aug 22.

• Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population

  Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Clin Chem. 2009; 55(10):1809-15. Epub 2009 Aug 13.

• Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications

  Ko DT, Chiu M, Guo H, Austin PC, Goeree R, Cohen E, Labinaz M, Tu JV. J Am Coll Cardiol. 2009; 53(19):1773-82.

• Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients

  Chiu M, Ko DT, Austin PC, Cohen EA, Velianou JL, Goeree R, Blackhouse G, Tu JV. Circ Cardiovasc Qual Outcomes. 2009; 2:96-107. Epub 2009 Mar 5.

• A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

  Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM. CMAJ. 2009; 180(7):713-8. Epub 2009 Jan 28.

• Canadian quality indicators for percutaneous coronary interventions

  Ko DT, Wijeysundera HC, Zhu X, Richards J, Tu JV; National Expert Panel. Can J Cardiol. 2008; 24(12):899-903.

• A survey of primary percutaneous coronary intervention for patients with ST segment elevation myocardial infarction in Canadian hospitals

  Ko DT, Donovan LR, Huynh T, Rinfret S, So DY, Love MP, Galbraith D, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2008; 24(11):839-43.

• Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction

  Austin PC, Tu JV, Ko DT, Alter DA. CMAJ. 2008; 179(9):901-8.

• Indicators of quality of care for patients with acute myocardial infarction

  Tu JV, Khalid L, Donovan LR, Ko DT; Canadian Cardiovascular Outcomes Research Team/Canadian Cardiovascular Society Acute Myocardial Infarction Quality Indicator Panel. CMAJ. 2008; 179(9):909-15.

• Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction

  Austin PC, Tu JV, Ko DT, Alter DA. CMAJ. 2008; 179(9):895-900.

• An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials

  Wijeysundera HC, You JJ, Nallamothu BK, Krumholz HM, Cantor WJ, Ko DT. Am Heart J. 2008; 156(3):564-72. Epub 2008 Jun 30.

• Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis

  Ko DT, Chiu M, Austin PC, Bowen J, Cohen EA, Tu JV. Am Heart J. 2008; 156(1):125-34. Epub 2008 May 6.

• Use of ezetimibe in the United States and Canada

  Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM. N Engl J Med. 2008; 358(17):1819-28. Epub 2008 Mar 30.

• Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction

  Ko DT, Wang Y, Alter DA, Curtis JP, Rathore SS, Stukel TA, Masoudi FA, Ross JS, Foody JM, Krumholz HM. J Am Coll Cardiol. 2008; 51(7):716-23.

• Life expectancy after an index hospitalization for patients with heart failure: a population-based study

  Ko DT, Alter DA, Austin PC, You JJ, Lee DS, Qiu F, Stukel TA, Tu JV. Am Heart J. 2008; 155(2):324-31.

• «
• 1
• 2
• 3
• 4
• 5
• 6
• »